Rapid Test Kit Detects Dengue Antibodies in Saliva
By LabMedica International staff writers Posted on 09 Feb 2015 |
Image: A three dimensional model of the rapid test kit that detects dengue-specific antibodies (Photo courtesy of the Agency for Science, Technology and Research, A*STAR).
A paper-based disposable device has been developed that will allow dengue-specific antibodies to be detected easily from saliva within 20 minutes and the device is currently undergoing further development.
Paper-based immunoassays, usually in the form of lateral flow tests, are currently the standard platform for home diagnostics. However, conventional lateral tests are often complicated by severe nonspecific adsorption of detector particles when applied to test samples containing salivary fluid.
Scientists at the Institute of Bioengineering and Nanotechnology (The Nanos; Singapore) developed a stacking flow device consisting of a test strip, a sample pad, a reagent pad, an absorbent pad, and a flow regulator. The sample and reagent pads were made of glass fiber, and the absorbent pad was made of cellulose (Merck Millipore, Billerica, Massachusetts, USA). The nitrocellulose test strip was cut into the required dimensions manually with a roller cutter. The detection of dengue-specific immunoglobulin G (IgG) was conducted using the liquid conjugate approach. The liquid conjugate was composed of protein G-conjugated 40 nm gold nanoparticles.
In the device, different flow paths are created for samples and reagents through a multiple stacked system. This allows the saliva sample to flow separately through a fiber glass matrix, which removes the substances that would interfere with the nanoparticle-based sensing system before it mixes with the sensor nanoparticles. The device’s configuration also helps to regulate the flow in the test strip, generating uniform test lines for more accurate results. The stacking flow immunoassay platform requires only one user activation step: both the sample and reagents are added at the same time in a single step. Both the sample and reagents react and flow concurrently in the test strip. The single-step procedure significantly improved the ease of usage of the test kit. The study was published on January 12, 2015, in the journal Lab on a Chip.
Related Links:
Institute of Bioengineering and Nanotechnology
Merck Millipore
Paper-based immunoassays, usually in the form of lateral flow tests, are currently the standard platform for home diagnostics. However, conventional lateral tests are often complicated by severe nonspecific adsorption of detector particles when applied to test samples containing salivary fluid.
Scientists at the Institute of Bioengineering and Nanotechnology (The Nanos; Singapore) developed a stacking flow device consisting of a test strip, a sample pad, a reagent pad, an absorbent pad, and a flow regulator. The sample and reagent pads were made of glass fiber, and the absorbent pad was made of cellulose (Merck Millipore, Billerica, Massachusetts, USA). The nitrocellulose test strip was cut into the required dimensions manually with a roller cutter. The detection of dengue-specific immunoglobulin G (IgG) was conducted using the liquid conjugate approach. The liquid conjugate was composed of protein G-conjugated 40 nm gold nanoparticles.
In the device, different flow paths are created for samples and reagents through a multiple stacked system. This allows the saliva sample to flow separately through a fiber glass matrix, which removes the substances that would interfere with the nanoparticle-based sensing system before it mixes with the sensor nanoparticles. The device’s configuration also helps to regulate the flow in the test strip, generating uniform test lines for more accurate results. The stacking flow immunoassay platform requires only one user activation step: both the sample and reagents are added at the same time in a single step. Both the sample and reagents react and flow concurrently in the test strip. The single-step procedure significantly improved the ease of usage of the test kit. The study was published on January 12, 2015, in the journal Lab on a Chip.
Related Links:
Institute of Bioengineering and Nanotechnology
Merck Millipore
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia